In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Meritage Pharma, Inc.

http://www.meritagepharma.com

Latest From Meritage Pharma, Inc.

Complaint Alleges Ellume Failed To Pay Refunds After Class I Recall Of OTC COVID-19 Tests

Complaint filed in Maryland federal court says Australian firm, which received more than $230 from US government to boost production of its OTC COVID-19 diagnostic tests available to US consumers, should’ve offered refunds to consumers who bought tests the company has recalled due to false positive tests.

Coronavirus COVID-19 Legal Issues

Ellume Faces Class-Action Suit After Class I Recall Of COVID-19 Tests

The lawsuit, filed in Maryland federal court, says Ellume should’ve offered refunds to people who bought later-recalled COVID-19 tests from the company.

Policy Legal Issues

Recall Of Millions Of Ellume COVID-19 Tests High-Risk Class I, FDA Says

Ellume recalled 2,212,335 of the home tests because there’s a chance they can give false-positive results.

Recalls Safety

Digital Health Roundup, March 2021: Record-Breaking Funding; Exec Chats With Medtronic, Edwards LifeSciences

In this new roundup feature focusing on the most notable developments in digital health, we pick the key news to date.

Digital Health Artificial Intelligence
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register